270,350 Shares in Ventas, Inc. $VTR Bought by Ceredex Value Advisors LLC

Ceredex Value Advisors LLC purchased a new stake in Ventas, Inc. (NYSE:VTR) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 270,350 shares of the real estate investment trust’s stock, valued at approximately $24,007,000. Ceredex Value Advisors LLC owned approximately 0.05% of Ventas as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. Deutsche Bank AG raised its position in Ventas by 0.7% during the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after purchasing an additional 27,688 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Ventas by 2.5% in the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock valued at $222,000,000 after purchasing an additional 70,459 shares during the last quarter. Norges Bank bought a new position in shares of Ventas in the 4th quarter valued at $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Ventas by 7.4% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after buying an additional 92,236 shares in the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC raised its holdings in shares of Ventas by 5.8% during the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock worth $143,305,000 after buying an additional 101,370 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on VTR shares. Mizuho raised their price objective on Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Royal Bank Of Canada increased their target price on shares of Ventas from $98.00 to $99.00 and gave the stock an “outperform” rating in a report on Friday, August 14th. Jefferies Financial Group raised their price target on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Barclays began coverage on shares of Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price target on the stock. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Ventas has an average rating of “Moderate Buy” and a consensus target price of $98.00.

Ventas Stock Performance

NYSE:VTR opened at $92.82 on Friday. The stock’s 50-day moving average is $91.18 and its 200-day moving average is $87.04. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The stock has a market cap of $47.61 billion, a P/E ratio of 171.89, a price-to-earnings-growth ratio of 2.12 and a beta of 0.69.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business earned $0.87 EPS. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. Equities research analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current year.

Insider Transactions at Ventas

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.53% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.